Cushing syndrome from topical foam steroid use in an adolescent male

Clinical Pediatrics

Volumn 45, Issue 1, 2006, Pages 97-100

  Gold Von Simson, Gabrielle ^a,b   Kohn, Brenda ^a   Axelrod, Felicia B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C PEPTIDE; CALCIUM; CHOLESTEROL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CORTICOTROPIN; CORTODOXONE; CREATININE; DEOXYCORTICOSTERONE; DEXAMETHASONE; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; HYDROXYPROGESTERONE; HYPOPHYSIS HORMONE; INSULIN; LOW DENSITY LIPOPROTEIN; PRASTERONE SULFATE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN C; STEROID; TESTOSTERONE; TRIACYLGLYCEROL; ULOBETASOL PROPIONATE; VITAMIN B COMPLEX; VITAMIN D;

ACNE; ADOLESCENT; ANXIETY DISORDER; ARTICLE; BONE ATROPHY; CASE REPORT; CUSHING SYNDROME; FACE ERYTHEMA; FOAM; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERTENSION; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; MALE; OSTEOLYSIS; PSORIASIS; WEIGHT GAIN;

ADMINISTRATION, TOPICAL; ADOLESCENT; BLOOD CHEMICAL ANALYSIS; CLOBETASOL; CUSHING SYNDROME; GLUCOCORTICOIDS; HUMANS; MALE; PROGNOSIS; PSORIASIS; RARE DISEASES; RISK ASSESSMENT; SCALP; SEVERITY OF ILLNESS INDEX; WEIGHT GAIN;

EID: 33644836658     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280604500118     Document Type: Article

References (10)

1. Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003;88(12):5593-5602.
2. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf). 1994;40:479-484.
3. Schuff KG. Issues in the diagnosis of Cushing's syndrome for the primary care physician. Primary Care Clin Office Pract. 2003;30:4.
4. Forget H, Lacroix A, Cohen H. Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneruoendocrinology. 2002;27:367-383.
5. Williams RH, Larsen PR, Kronenberg HM, et al. Williams Textbook of Endocrinology, 10th ed. St. Louis: Elsevier, 2003.
6. Kumar S, Singh RJ, Reed AM, Lteif AN. Cushing's syndrome after intraarticular and intradermal administration of triamcinolone acetonide in three pediatrie patients. Pediatrics. 2004;113:1820-1824.
7. Allen DB, Bielory L, Derendorf H, et al. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol. 2003;112:S1-40.
8. Ermis B, Ors R, Tastekin A, Ozkan B. Cushing's syndrome secondary to topical corticosteroids abuse. Clin Endocrinol. 2003;58:795-796.
9. Vermeer H, Hendriks-Stegeman BI, van der Burg B, et al. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab. 2003;88:277-284.
10. Murray L. Physicians' Desk Reference. Montvale, NJ: Medical Economics, 2001.